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Abstract
Background: Sleep disturbances are a chronic and challenging pro-
blem in cancer patients, often associated with multiple factors such 
as depression, anxiety, fatigue and pain. 
Aim: The purpose of this integrative review is to evaluate the literature 
on sleep quality in women with breast cancer and the influence that 
poor sleep quality has on health. 
Methods: Between 2009 and 2016, a search of PubMed, CINAHL, 
PsycINFO, Cochrane and Joanna Briggs databases with the descriptors 
sleep quality and breast cancer resulted in 27 studies that met the 
review criteria. The review questions were: How is the sleep quality 
in women with breast cancer? What health issues are associated with 
poor sleep quality in women with breast cancer? 
Results: Findings support the presence of poor sleep quality in many 
women with breast cancer, before, during and after treatment asso-
ciated with health issues. 
Conclusions: Sleep disruptions are associated with breast cancer in 
woman, and affects their overall health. It is essential for nurses to 
identify sleep disorders and their impact on the health and quality of 
life of women with breast cancer. A deeper understanding of sleep 
quality in women with breast cancer can increase cancer nurses’ skill 
in caring for their patients. 
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It is estimated that until 2020, the number of new cases of cancer 
per year will be about 15 million, of which about 60 % will occur in 
developing countries. [1] Breast cancer is the second most frequent 
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type of cancer in the world, and the most common 
cancer in women [1]. During 2010, in the United 
States, over 207,000 women were diagnosed with 
breast cancer [2].
Sleep disturbances occur in all types of cancer pa-
tients, and are associated with multiple factors such 
as depression, anxiety, treatment (e.g., chemothera-
py radiation and surgery), cancer treatment-induced 
hot flashes, pain, fatigue and changes in biological 
rhythms [3]. Most studies do not consider whether 
sleep changes are associated with baseline sleep 
quality, baseline mental and physical health, de-
mographic and clinical variables. Such associations 
might lead clinicians to target those at high risk for 
sleep problems [4].
An important study showed that better sleep ef-
ficiency was found to predict a significant reduction 
in overall mortality [5]. Additional research is needed 
to determine if beginning treatment of these symp-
toms before the start of chemotherapy will minimi-
ze symptom severity over time [6]. 
Sleep problems occur in many patients with cancer 
resulting in sleep deprivation that may affect their 
immunological status. Sleep deprivation produces 
a stress reaction in the body, being immunologi-
cally best characterized as an increase in leukocyte 
and neutrophil count, and in serum C-reactive pro-
tein rates. An experimental study conducted with 
healthy subjects showed that a single night of sleep 
deprivation is sufficient to cause these increases that 
return to baseline only with ten hours of recovery 
sleep. Cancer patients experiencing chronic sleep 
loss may be more vulnerable to these immunologi-
cal changes because of the obstacles in obtaining 
sufficient recovery sleep, thus mounting an exacer-
bated and sustained inflammatory response [7].
Furthermore, Liu et al [8] reports a longitudinal 
relationship between fatigue, sleep parameters, 
and inflammation in breast cancer patients. The-
se authors found that changes in reports of sleep 
quality were significantly associated with a decrease 
in circulating levels of IL-1RA. Additionally, there are 
changes in fatigue and sleep quality that were sig-
nificantly associated with an increase in circulating 
levels of IL-6, and the relationship between sleep 
quality and IL-6 was likely driven by fatigue. 
When sleep disturbances become chronic, nurses 
need to make recommendations and referrals [9]. 
Because the sleep disturbances are common among 
breast cancer survivors, even after completion of 
active cancer treatment [10]. 
In a study aimed to associate breast cancer symp-
toms with sleep quality, [11] researchers found poor 
sleep quality present in 85% of women. A follow-
up of those women, 2 to 7 months after baseline, 
revealed that 20% of those who reported poor 
sleep quality had worsening of clinical symptoms 
and 8% died [11, 7] The recognition that poor sleep 
quality may represent a prognostic factor in cancer 
patients should encourage nurses and other health 
professionals to give special attention to this impor-
tant aspect of routine life [4, 12] 
Methods
Review Questions
The purpose of this review is to evaluate the scienti-
fic literature on sleep quality in women with breast 
cancer, and to assist nurses with understanding the 
potential health effect of poor sleep quality. The 
review questions are: 
1)  How is the sleep quality in women with breast 
cancer?
2)  What health issues are associate with poor 
sleep quality in women with breast cancer?
Search Criteria
The population of concern is women (18 years or 
older), diagnosed with any type of breast cancer, 
and who are undergoing any treatment. Additional 
inclusion criteria are full-text articles, published in 
the last eight years (2009-2016), and in English. The 
primary outcome measure of interest is sleep quality 
including sleep, sleep duration, sleep disturbance, 
insomnia, and circadian-rhythms. This review con-
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siders both experimental and epidemiological stu-
dy designs including randomized controlled trials, 
non-randomized controlled trials, quasi-experimen-
tal, before and after studies, prospective and re-
trospective cohort studies, case control studies and 
analytical cross sectional studies.
Search Strategy
An initial search of PubMed, CINAHL, PsycINFO, 
Cochrane database of systematic reviews and Joa-
nna Briggs databases was undertaken. The title, 
abstract, and keywords of the articles were re-
viewed for relevance to the inclusion criteria. The 
following combinations of keywords were used 
in the search; sleep quality (sleep quality analysis, 
sleep quality assessment, sleep quality characteris-
tics, sleep quality evaluation, sleep quality distur-
bance) and breast cancer (breast neoplasm, breast 
cancer symptoms, breast cancer fibroblast, breast 
cancer experimental). 
Data collection was performed utilizing an instru-
ment to identify the publication (main authors, year 
of publication), research purpose, methodological 
characteristics (design, sample, and instruments), 
and findings with conclusions on sleep quality and 
associated health issues.
Results
We selected 27 studies for review from an initial 
search in which 634 articles were found as outlined 
in the Figure 1. 
Of the 634 articles found in the databases sear-
ched, we retrieved 27 articles that met the inclusion 
criteria as outlined in the Table 1. 
Levels of Evidence by the Joanna Briggs Institute 
(JBI) Levels of Evidence and Grades of Recommen-
dation Working on Table 2. [13].
Figure 1: Study selection process and results.
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Table 1. Summary of Research on Sleep Quality and Associated Health Issues in Women with Breast Cancer.
Authors Year Research Purpose Design Sample Instruments Finding / Conclusions on Sleep QualityAssociated Health Issues
Berger (2009) Level 1.a. To determine 
whether sleep quality and fatigue 
are associated with breast cancer 
adjuvant chemotherapy treatments 
and can be improved with 
behavioral therapy (BT) including 
modified stimulus control, modified 
sleep restriction, relaxation therapy, 
and sleep hygiene
Randomized-
controlled trial based 
on Piper Integrated 
Fatigue Model 
-Longitudinal
219 females stage, 
I–IIIA breast cancer, 
-BT participants had 
an  Individualized Sleep 
Promotion Plan (ISPP),  
-Controls received healthy 
eating information (HEC) 
Pittsburgh Sleep Quality 
Index (PSQI) , sleep diary and 
actigraphy (48 hrs prior to initial 
treatment, 7 days/nights at each 
treatment,  7 days/nights 30 
days after last treatment), Piper 
Fatigue Scale (PFS), Symptoms 
Experience Scale (SES), Hospital 
Anxiety and Depression Scale, 
Medical Outcomes Study Short-
form General Health Survey
Daily sleep diary and actigraphy
data revealed sleep near or within normal limits, except for number of 
awakenings and longer wake after sleep onset 
Participants reported mild Fatigue, poor sleep quality, normal anxiety and 
depression levels and low physical functioning
Significant differences over time on all sleep variables obtained by diary 
and actigraphy [all P< .01]
Changes in sleep quality (PSQI) in the groups over time [P = .003]
BT group showed improved sleep quality over time on sleep per diary and 
actigraphy [less awakenings 
P = .032 and P = .03; higher efficiency P = .027 and total sleep time P = 
.09] 
Mean PSQI scores in both groups were greater than 5 but less than 8 at 
all measurements, reflecting fairly poor sleep quality 
Peri-and postmenopausal women in the  HEC group rated poorer sleep 
quality than ISPP group
Menopausal status when starting chemotherapy was associated with 
differing patterns of poor sleep and hot flashes over time
Difficulty maintaining sleep was evident by  higher than normal (2-6) 
number of awakenings per night (6-12) Mean number of awakenings 
varied significantly over time  P= .04-Minutes awake after sleep onset per 
night over time varied widely, and was higher than normal values
Banthia  (2009) Level 3.e. To examine age, 
cancer stage, sleep quality and 
depressed mood as predictors of 
five dimensions of fatigue 
Cross-sectional 70 fatigued female breast 
cancer survivors with 
a minimum of 5 on the 
Multidimensional Fatigue 
Symptom Inventory-Short 
Form (MFSI-SF) 
 General fatigue scale, 
MFSI-SF, PSQI, and Center 
for Epidemiological Studies-
Depression Scale (CES-D)
PSQI global score was significantly correlated with the CES-D total score 
and all MFSI-SF subscales, except mental fatigue 
Correlations of greatest magnitude were general [.44] and physical [.42] 
fatigue
Simple bivariate relationships of the four predictors (age, cancer stage, 
CES-D and PSQI Variables that had coefficients above an absolute value 
of .33 were interpreted as strong predictors
Higher scores on the PSQI predicted membership in the higher fatigue 
group for general and physical fatigue
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Authors Year Research Purpose Design Sample Instruments Finding / Conclusions on Sleep QualityAssociated Health Issues
Dirksen  (2009). Level 1.b. To determine 
if breast cancer survivors with 
insomnia can be grouped according 
to their level of fatigue
Secondary data 
analysis of baseline 
data from a 
randomized control 
trial
86 female breast cancer 
survivors with insomnia
Profile of Mood States Fatigue 
(POMS F/I), Insomnia Severity 
Index (ISI), State-Trait Anxiety 
Inventory (STAI), CES-D
58(68%) had clinically significant insomnia (ISI score >15)  20 (24%) had 
clinically significant level of depression (CES-D score >16) Significant 
differences were also noted on anxiety, with the Restored and Tired 
groups having a significantly lower level of state and trait anxiety 
compared to the Exhausted group  Exhausted group had a significantly 
higher level of depression in comparison to the Tired and Restored groups
Otte  (2010) Level 3.d. To refine 
knowledge regarding prevalence, 
severity, and correlates of sleep-
wake disturbances in long-term 
breast cancer survivors compared 
to age-matched women without 
breast cancer (WWC).
Cross-sectional, 
comparative, case-
controlled 
246 female breast cancer 
survivors (BCS) and 246 
women without breast cancer 
(WWC)
RAND Physical Functioning-10 
(PF-10), PSQI, CES-D, Concerns 
about Recurrence Scale (CARS), 
Impact of Events Scale (IES)
BCS had significantly more prevalent sleep-wake disturbances (65%) 
compared to WWC (55%) [P <.05)]
BCS had significantly higher PSQI global scores indicating poorer sleep 
quality compared to WWC [P <.05]
Significant correlates of poor sleep prevalence for BCS included hot 
flashes, poor physical functioning, depressive symptoms and distress 
WWC had higher impact of a life event reflected by higher mean scores 
for the IES P < .05
Thomas  (2009)  Level 3.e. To examine 
changes in sleep and coping as a 
predictor of sleep during radiation 
therapy and over a 6- month follow 
up
Longitudinal 33 women with breast 
cancer (BC) and 23 men with 
prostate cancer (PC) Self-
reported sleep was assessed 
at eight time points before, 
during, and after treatment
Medical Outcomes Study Health 
Survey (MOS), Sleep Scale (MOS-
Sleep), COPE Inventory (COPE-
brief), Cancer treatment-related 
symptoms scales
BC and PC patients reported the most sleep problems prior to and during 
the early weeks of treatment [P<.05]
Significant relationship between depressed mood and sleep latency over 
time in a regression analysis.
On weeks when patients reported more depression, took longer to fall 
asleep [P=.13]
Beck  (2010) Level 1.b. To characterize 
sleep quality and quantity prior to 
and in the first 3 nights after initial 
chemotherapy for breast cancer
Secondary analysis 
from two data sets
183 women with breast 
cancer
 PSQI, actigraphy, MOS 65% were poor sleepers, 25.7% had “fairly bad” or “very bad” overall 
sleep quality on PSQI (Item 6) at baseline
3 nights of actigraphy recorded a wide range of sleep experience with an 
average of 10 awakenings, first night sleep worst 
Poor sleep at baseline had significantly lower [P< .001] physical (MOS 
PCS) and mental (MOS MCS) health status 
Garrett  (2011) Level 3.e. To evaluate for 
differences in the occurrence rates 
of sleep disturbances and fatigue
Cross-sectional Women with breast (N =78) 
and men with prostate (N 
=82) cancer 
PSQI, General Sleep Disturbance 
Scale (GSDS), Lee Fatigue Scale 
(LFS), actigraphy 
Breast cancer patients reported significantly longer sleep onset latency 
[P=.02], significantly more sleep disturbances [P <.001], and significantly 
greater daytime dysfunction [P=.003]
Mean PSQI global score was significantly higher in the patients with 
breast cancer than prostate cancer [P=.08].
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Authors Year Research Purpose Design Sample Instruments Finding / Conclusions on Sleep QualityAssociated Health Issues
Wu  (2011)  Level 1.b. To characterize 
and compare disrupted sleep 
patterns in fatigued breast cancer 
patients receiving chemotherapy 
with postmenopausal women 
without a history of cancer
Secondary data 
analysis from two 
studies
30 fatigued female breast 
cancer (BC) chemotherapy 
outpatients and 32 non-
cancer postmenopausal 
women
PSQI and STA BC patients showed significant sleep difficulties; prolonged sleep onset 
latency [M= 54.3, SD= 49.2 minutes] and frequent nighttime awakenings, 
despite 40% of the patients using sleep medications three or more times 
a week 
Compared to the non-cancer group, fatigued cancer patients reported 
significantly longer sleep latency [P=.041], more use of sleep medications 
[P=.06], and higher total PSQI scores [P=.05] 
STAI scores did not differ between the two groups [P=.88]
Alfano  (2011) . Level 3.e. To investigate 
patterns of sleepduration change 
across the early breast cancer 
survivorship period, demographic 
and clinical predictors, and 
relationships with subsequent 
cancer-related symptoms and 
health-related quality of life 
(HRQOL)
Longitudinal: 6 
months post-
diagnosis, 30 months 
post-diagnosis and 
39 months post-
diagnosis
572 female breast cancer 
survivors 
Modifiable Activity 
Questionnaire, PFS, Perceived 
Stress Scale (PSS), CARS, SF-36
-Mean total sleep time about 7 hours at each time point [SD=1,2; range 
for each 3.5–9]
25% had sleep duration change over time; temporary (5.6%), late-
occurring (14%), or sustained (5.9%)
Sustained sleep changes were related to greater subsequent severity, 
affective, and sensory aspects of fatigue [P= all<.01]
Mosher 
and 
DuHamel 
 (2012)  Level 3.e- To assess the 
prevalence of distress among 
metastatic cancer patients using 
Distress Thermometer (DT)
Cross-sectional- 
telephone survey 
1 week after DT 
to assess anxiety, 
depressive symptoms, 
sleep problems, and 
fatigue.
173 female metastatic breast 
cancer patients
DT, PSQI, CES-D, Hospital 
Anxiety and Depression Scale, 
Functional Assessment of 
Chronic Illness Therapy Fatigue 
subscale, Karnofsky Performance 
Status Scale (KPS) 
70% had PSQI scores greater than 5 [95% CI=59–79%], indicating 
significant decrements in sleep quality
60% met the clinical cutoff (4) for probable distress on the DT 
Younger women had higher levels of anxiety [P<.05], greater medical 
comorbidities were associated with greater depressive symptoms [P<.05], 
greater fatigue [P<.05], and poorer sleep quality [P<.05]
Liu  (2012) Level 3.e.To explore the 
longitudinal relationship between 
fatigue and sleep measured both 
subjectively and objectively
Longitudinal 97women with newly 
diagnosed stage I-III breast 
cancer, scheduled to receive 
at least four 3-week cycles of 
chemotherapyData collected 
at 7 time points: before 
(baseline) and during the 3 
weeks of cycle 1   through 
cycle 4 chemotherapy 
(C=cycle and W=week)
PSQI, actigraphy, MFSI-SF Mean PSQI scores indicated poor sleep quality at all 7 time points 
At baseline, 61% reported PSQI > 5 and 32% PSQI > 8; at the end of 
treatment (C4W33), 76% PSQI > 5 and42% PSQI > 8
Subjective sleep quality was poor at baseline and remained unchanged 
throughout treatment. There was a significant overall time effect[P<.001] 
for total sleep time
Significant negative correlations between total wake time during the day 
(WAKE) and MFSI-SF General [P = .03] and Physical [P = .05] subscale 
scores at C1W1, and significant positive correlation between WAKE and 
MFSI-SF Vigor subscale scores [P=.04]
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Dhruva  (2012)  Level 3.e.To 
examine how actigraphy 
and self-report ratings 
of sleep disturbance 
changed over the course 
of and following radiation 
therapy (RT)
Longitudinal 73 women with breast 
cancer
Actigraphy, GSDS, KPS scale, 
LFS,CES-D, Spielberg State-Trait 
Anxiety, Brief Pain Inventory  
For actigraphy, 87% had an excessive number of awakenings, 46% had an abnormal 
Wake After Sleep Onset (WASO), and 58% had Total Seep Time (TST) below healthy adult 
values
More than 85% of the patients had high number of nighttime awakenings
Approximately 50% had abnormal WASO and total GSDS scores at the initiation of RT
Comorbidity, evening fatigue, and depressive symptoms predicted baseline levels of 
subjective sleep disturbance, and depressive symptoms predicted the trajectory of 
subjective sleep disturbance
Girschik  (2013) Levels of 
Evidence:3.d
population-based 
case-control study
control: 1695, 
Case:1133
a self-administered postal 
questionnaire that contained 
questions on demographic, 
reproductive, and lifestyle 
factors as well as sleep. The 
domains of sleep investigated 
were: usual duration of sleep 
on workdays; usual duration 
of sleep on nonworkdays; and 
subjective sleep quality.
no association between
self-reported sleep duration on workdays and risk of breast cancer (for <6 hours, odds 
ratio (OR) = 1.05 (95% CI: 0.82, 1.33); for 6–7 hours, OR = 0.96 (95% CI: 0.80, 1.16); 
and for >8 hours, OR = 1.10 (95% CI: 0.87, 1.39), compared with the reference category 
of 7–8 hours’ sleep). In addition, we found no association between sleep duration on 
nonworkdays, subjective sleep quality, or combined duration and quality and risk of breast 
cancer. This study does not provide evidence to support an association between self-
reported sleep duration or quality and the risk of breast cancer.
Aldridge-
Gerry 
 (2013) Levels of 
Evidence:3.e
observational  Women with 
metastatic breast 
câncer MBC (N=103) 
3 nights of polysomnography 
(PSG).
Women with MBC who reported more depressive symptoms had lighter sleep (e.g., stage 
1 sleep; P<.05), less slow-wave sleep (SWS) (P<.05), and less rapid eye movement (REM) 
sleep (P<.05). Single women had less total sleep time (TST) (P<.01), more wake after sleep 
onset (WASO) (P<.05), worse sleep efficiency (SE) (P<.05), lighter sleep (e.g., stage 1; 
P<.05), and less REM sleep (P<.05) than married women.
Women with MBC and greater symptoms of depression had increased light sleep and 
reduced SWS and REM,
Liu  (2013) Levels of 
Evidence:3.e
longitudinal 166 women with 
newly diagnosed stage 
I-III breast. Câncer
Medical Outcomes Study-Short 
Form Physical Component Scale 
and Mental Component Scale 
scores. Subjective sleep was 
assessed with the Pittsburgh 
Sleep Quality Index (PSQI); 
objective sleep was measured 
with actigraphy.
Patients reported poor HRQOL and poor sleep quality before and during chemotherapy. 
Short sleep time and long naps were recorded at both time points. The Mental Component 
score was related to reports of poor sleep but not to recorded sleep, worse Physical 
Component scores were associated with reports of poor sleep and less recorded nap time, 
suggesting sleep plays an important role in cancer patients’ HRQOL.
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Tell  (2014) Levels of 
Evidence:3.e
Longitudinal Women (N=130, collected saliva 5×/day/2 days for cortisol; 
Diaries;Multidimensional Fatigue Symptom 
Inventory and the Pittsburg Sleep Quality 
Inventory.
Greater ongoing fatigue (b=0.035, p = .032), or sleep disturbance 
(b=0.026, p = .006) predicted a slower cortisol decline.
Longer sleep latency predicted both a greater cortisol linear decline 
(b=−0.013, p < .001).
Both daily variations in sleep behaviors and ongoing sleep disturbance 
and fatigue associated with a disrupted cortisol rhythm
Garland  (2014) Levels of 
Evidence:3.d
case control  70 women with moderate to severe 
insomnia symptoms and a matched 
comparison group of 70 women 
without insomnia symptoms (n = 
140). 
Insomnia Severity Index (ISI); The Hospital 
Anxiety and Depression Scale (HADS) ;The 
Brief Fatigue Inventory (BFI)
Women with significant insomnia symptoms had higher levels of 
unemployment compared to women without insomnia. TL (telomere 
lengh) was positively skewed and shorter in the insomnia group.
Women with insomnia also reported significantly higher levels of 
depression ( p < 0.001), anxiety ( p < 0.001), and fatigue ( p < 0.001).
Mao  (2014) Levels of 
Evidence:1.a
randomized 
Trial
67 randomly assigned patients, of 
an eight-week course of electro-
acupuncture (EA) as compared to 
waitlist control (WLC) and sham 
acupuncture (SA) in postmenopausal 
women with breast cancer
 Brief Fatigue Inventory (BFI), Pittsburgh 
Sleep Quality Index (PSQI), and Hospital 
Anxiety and Depression Scale (HADS).
baseline pain interference was associated with fatigue (Pearson 
correlation coefficient r =0.75, p<0.001), sleep disturbance (r=0.38, 
p=0.0026), and depression (r= 0.58, p<0.001). 
Compared to the WLC, EA produced significant improvement in fatigue 
(p=0.0095), anxiety (p=0.044), and depression (p=0.015)
Compared to usual care, EA produced significant improvement in fatigue, 
anxiety, and depression, whereas SA improved only depression in women 
experiencing AI-related arthralgia.
Palesh  (2014) Levels of 
Evidence:3.e
Longitudinal among 97 women. wrist-worn actigraphy and sleep diaries for 
3 days
better sleep efficiency was found to predict a significant reduction 
in overall mortality (hazard ratio [HR], 0.96; 95% confidence interval 
[CI], 0.94–0.98; P < 0.001) at median 6 y follow-up. This relationship 
remained significant (HR, 0.94; 95% CI, 0.91–0.97; P < 0.001) even 
after adjusting for other known prognostic factors (age, estrogen 
receptor status, cancer treatment, metastatic spread, cortisol levels, and 
depression).
These findings show that better sleep efficiency and less sleep disruption 
are significant independent prognostic factors in women with advanced 
breast cancer. Further research is needed
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Ancoli-
Israel 
 (2014) Levels of Evidence:3.e Longitudinal  Sixty-eight women with 
stage I-III breast cancer (BC) 
scheduled to receive ≥4 
cycles of chemotherapy 
actigraphy (nocturnal total 
sleep time [nocturnal TST] 
and daytime total nap time 
[NAPTIME]) and with the 
Pittsburgh Sleep Quality 
Index (PSQI); fatigue with 
the Multidimensional Fatigue 
Symptom Inventory-Short Form 
(MFSI-SF); depression with 
the Center of Epidemiological 
Studies-Depression (CES-D). 
CARs were derived from 
actigraphy.
Compared to NC, BC had longer NAPTIME, worse sleep quality, more 
fatigue, more depressive symptoms, more disrupted CARs and worse QoL 
at Baseline
Cycle-4, BC showed worse sleep, increased fatigue, more depressive 
symptoms, and more disrupted CARs compared to their own Baseline 
levels and to NC (all p’s<0.05). By 1-year, BC’s fatigue, depressive 
symptoms and QoL returned to Baseline levels but were still worse than 
those of NC, while NAPTIME and CARs did not differ from NC’s
Additional research is needed to determine if beginning treatment of 
these symptoms before the start of chemotherapy will minimize symptom 
severity over time.
Chen  (2014) Levels of Evidence:1.a randomized, placebo-
controlled trial
95 postmenopausal women 
with a prior history of stage 
0-III breast cancer 
 Pittsburgh Sleep Quality Index 
(PSQI), Depression (CES-D), 
and the North Central Cancer 
TreatmentGroup (NCCTG) hot 
flash diary,
At baseline, 52% of participants reported poor sleep in the month prior 
to enrollment. Compared to subjects on placebo, subjects randomized to 
melatonin experienced significantly greater improvements in subjective 
sleep quality as measured by the PSQI, including domains on sleep quality, 
daytime dysfunction and total score.
Sleep disturbances are common among breast cancer survivors, even 
after completion of active cancer treatment. This is the first randomized 
placebo-controlled study among breast cancer survivors to demonstrate 
that melatonin was associated with an improvement in subjective sleep 
quality, without any significant adverse effects.
Ratcliff  (2014) Levels of Evidence:3.e longitudinal Twenty women undergoing 
CT for breast cancer
 Pittsburgh Sleep Quality Index 
(PSQI)and mood three times 
daily (morning, afternoon, 
and evening) via ecological 
momentary assessments (EMAs) 
using automated handheld 
computers.
The results showed that disturbed sleep (PSQI score ≥5) prior to CT 
infusion was associated with greater fatigue, and more negative and 
anxious mood throughout the 3 week CT cycle, and good pre-CT infusion 
sleep (PSQI score <5) buffered anxious mood in the first days following 
infusion.
No evening symptom or mood ratings were related to subsequent sleep 
quality.
These findings suggest that disturbed sleep before and after a CT infusion 
exacerbates fatigue, and negative, anxious, and drowsy mood during a CT 
cycle. Reducing sleep disturbance may be an important way to improve 
quality of life during chemotherapy.
InternatIonal archIves of MedIcIne 
sectIon: nursIng
ISSN: 1755-7682
2016
Vol. 9 No. 359
doi: 10.3823/2230
This article is available at: www.intarchmed.com and www.medbrary.com 10
Authors Year Research Purpose Design Sample Instruments Finding / Conclusions on Sleep QualityAssociated Health Issues
Vargas   (2014) Levels of Evidence:1.  intervention Trial  Patients were randomized 
to CBSM (n = 120) or a one-
day psychoeducation control 
group (n = 120). 
Pittsburgh Sleep Quality Index 
(PSQI) and Fatigue Symptom 
Inventory were completed prior 
to randomization and 6 and 
12 months after the baseline 
assignment
In latent growth analyses, women in CBSM reported greater 
improvements in PSQI sleep quality scores than controls, although there 
were no significant differences between conditions on PSQI total scores
Future work may consider integrating sleep and fatigue content into stress 
management interventions for women with early-stage breast cancer.
Roscoe  (2014) Levels of Evidence:1* randomized trial 96 cancer survivors Insomnia Severity Index and 
sleep quality by the Pittsburgh 
Sleep Quality Inventory; sleep 
hygiene instructions. 
Analyses controlling for baseline differences showed that both the CBT-I 
(cognitive behavioral therapy for insomnia ) plus A (P _ .001) and CBT-I 
plus P (P _ .010) groups had significantly greater reductions in insomnia.
CBT-I results in significant and durable improvements in insomnia and 
sleep quality
Rogers  (2015)  Levels of Evidence:1.a Pilot randomized 
controlled trial
Forty-six postmenopausal 
BCS (≤ Stage II, off primary 
treatment) were randomized 
to a 3-month exercise 
intervention or control group. 
PSQI and PROMIS®), objective 
sleep quality (accelerometer), 
serum cytokines, 
accelerometer physical activity, 
cardiorespiratory fitness, body 
composition, fatigue, and 
psychosocial factors.
When compared with control, the intervention group demonstrated a 
significant increase in PSQI sleep duration (i.e., fewer hours of sleep/night) 
(d=0.73, p=.03). Medium to large but non-significant standardized effect 
sizes were noted for PSQI daytime somnolence (d=-0.63, p=.05) and 
accelerometer latency (d=-0.49, p=.14).
Inflammation and psychosocial factors may mediate or enhance sleep 
response to our exercise intervention. Further study is warranted to 
confirm our results
Lengacher  (2015)  Levels of Evidence: 1.a randomized 
controlled 
Seventy-nine BCS 
participants
sleep diaries and the Pittsburg 
Sleep Quality Index (PSQI)) and 
objective sleep parameters (OSP) 
(i.e., actigraphy) were measured 
at baseline, six weeks and 12 
weeks after completing the 
MBSR(BC) or UC program.
Results showed indications of a positive effect of MBSR(BC) on OSP at 12 
weeks on sleep efficiency
These data suggest that MBSR(BC) may be an efficacious treatment to 
improve objective and subjective sleep parameters in BCS.
* Levels of Evidence is developed by the Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party October 2013 [13]. 
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Characteristics of the Studies
A variety of journals has published articles on sleep 
quality in breast cancer patients over the last years. 
The largest number of articles was found in the 
Psycho-Oncology Journal and in the Journal of Pain 
Symptom Management, with 3 articles each. The-
re were articles published in several international 
oncology journals such as the European Journal of 
Oncology Nursing and Cancer Nursing, as well as in 
more general publications such as Psychology and 
Health. Regarding the year of publication, 5 articles 
were published in 2009, 2 in 2010, 3 in 2011, 4 in 
2012, 2 in 2013, 8 in 2014 and 3 in 2015. 
Nurse investigators, including five PhD prepared 
lead authors, contributed to a majority of the stu-
dies. The participation of undergraduate nursing 
students is noted in 2 articles [14, 15]. Inter-pro-
fessional collaboration in researches is important, 
and this was evident in the majority of these arti-
cles with contributions from medicine, nursing, and 
psychology. 
All studies in this review utilized a quantitative 
methodology, with 13 cross-sectional studies and 
20 longitudinal studies. We emphasize the impor-
tance of longitudinal studies because analyzing the 
patient in 2 or more stages of treatment and docu-
menting the difference in quality of sleep, may be 
helpful to nurses in managing their patients care. 
Nine articles reported randomized clinical trials [8, 
10, 16-21] and 3 were a secondary analysis [4, 22-
23].
In the studies selected for this review, the most 
common instrument used for data collection was 
the Pittsburgh Sleep Quality Index (PSQI) in 9 stu-
dies [2-4, 6, 9, 10, 14-17, 19-22, 24, 25], followed 
by actigraphy in 7 studies [6, 17, 18, 22, 25-27] , 
sleep diaries in 6 studies [6, 17, 18, 22, 25-27] and 
general questions in 1 study [15]. 
How Is the Sleep Quality in Women with 
Breast Cancer?
All 27 studies in this review found a significant level 
of sleep disturbance in women with breast cancer 
at various stages in their treatment. A summary of 
the findings is in Table 1.
Studies using the PSQI documented poor sleep 
quality for 65% to 70% of the participants [4, 28] 
and, actigraphy verified that up to 87% of the sample 
had an excessive number of awakenings.13Moreover, 
sleep diary records identified that difficulty maintai-
ning sleep was evident by the higher than normal 
(2-6) number of awakenings per night (6-12) [27].
Common sleep-time complaints noted in all of 
these studies is time spent in bed without sleeping, 
difficulty returning to sleep, decreased nocturnal 
sleep duration, increased sleep latency and waking 
earlier than desired. Additionally, the associated 
wake-time symptoms of sleepiness, fatigue, increa-
sed naps, cognitive impairment, and performance 
are also prevalent.
Mosher and Duhamel report that 70% of the pa-
tients completing the PSQI had scores greater than 
the cutoff point of five, indicating significant decre-
ments in sleep quality [28]. In a longitudinal study, 
more than 85% of the patients had a high number 
of nighttime awakenings [16]. When comparing wo-
Table 2. Levels Of Evidence For Effectiveness BY JBI.
Level 3
Observational Analytic Designs
a Systematic review of comparable cohort studies 
b Systematic review of comparable cohort and other 
lower study designs 
c Cohort study with control group 
d Case – controlled study 
.e Observational study without a control group 
Level 1
Observational Analytic Designs
a Randomized Controlled Trials (RCTs)
b RCTs and other study designs 
c RCT
d Pseudo-RCTs 
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men with cancer-related fatigue and postmenopau-
sal women without cancer, the authors found that 
breast cancer patients showed significantly more 
sleep difficulties [27]. These sleep problems were 
characterized by prolonged sleep onset latency (M= 
54.3, SD= 49.2 minutes) and frequent nighttime 
awakenings, despite 40% of the patients using 
sleep medications three or more times a week [16]. 
Greater ongoing fatigue or sleep disturbance pre-
dicted a slower cortisol decline, and longer sleep 
latency predicted both a greater cortisol linear de-
cline and slower cortisol decline [9]. 
Several studies elucidate how the sleep quality 
changed during cancer treatments such as che-
motherapy or radiotherapy. Considering the PSQI 
score >5 that represents poor quality sleep, [29] 
found that 65% of women self-reported poor 
sleep in the month preceding chemotherapy. 
Subjective sleep quality was poor at baseline and 
remained unchanged throughout treatment [3]. 
Half of the survivors reported no sleep duration 
change over time; however, 25% reported sleep 
changes indicating a temporary (5.6%), late-oc-
curring (14%), or sustained (5.9%) change [15]. 
Patients reported poor quality of life and poor 
sleep quality before and during chemotherapy 
with short sleep time and long naps recorded at 
both time points [26]. 
Prior to chemotherapy, participants’ related mild 
fatigue, and poor sleep quality; after an interven-
tion using behavior therapy, they perceived increa-
sed sleep quality [27]. On Cycle-4 chemotherapy, 
the breast cancer patients showed worse sleep, 
increased fatigue and more depressive symptoms, 
compared to their baseline levels [6].
A study suggests that disturbed sleep before and 
after a chemotherapy infusion exacerbates fatigue 
and anxiety [30]. Authors concluded that reducing 
sleep disturbance may be an important way to im-
prove quality of life during chemotherapy [30]. 
Other studies reported using an intervention 
and the authors concluded that future work might 
consider integrating sleep and fatigue content into 
stress management interventions for women with 
early-stage breast cancer [20]. Compared to usual 
care, eletro acupuncture produced significant im-
provement in fatigue, anxiety and depression [21]. 
The cognitive behavioral therapy for insomnia was 
used and showed durable improvements in insom-
nia and sleep quality [19].
A few researchers compare the sleep quality in 
those with breast cancer to other types of cancer. 
For instance, 2 articles compare women with breast 
cancer (BC) and men with prostate cancer (PC). Both 
BC and PC patients report the most sleep problems 
prior to and during chemotherapy. [14] The occu-
rrence rates for sleep disturbance and fatigue were 
significantly higher in patients with breast cancer as 
compared to prostate cancer [2].
Future work may consider integrating sleep and 
fatigue content into stress management interven-
tions for women with early-stage breast cancer [20]. 
What Health Issues Are Associated with 
Poor Quality Sleep in Women with Breast 
Cancer?
Poor sleep quality is reported in all 27 studies and 
is associated with several health issues such as se-
vere fatigue, depression, anxiety, hot flashes, pain, 
and generally poorer quality of life. A significant 
relationship between fatigue and sleep disturbances 
was found in 3 studies [2, 3, 9, 2, 3, 28, 30] and 
higher scores on the PSQI predicted membership in 
the higher fatigue group for general and physical 
fatigue. [31]
 Participants with breast cancer self-reported sig-
nificantly higher levels of sleep disturbance (P=.008) 
and fatigue (P=.005) than patients with prosta-
te cancer [2]. Fatigue was significantly associated 
with subjective reports of poor sleep and objecti-
ve measures of daytime sleepiness; however, not 
with nocturnal sleep as measured by actigraphy [3].
Additionally, there is a high prevalence of distress, 
sleep problems, and fatigue across demographic 
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and medical subgroups of metastatic breast cancer 
patients [28].
The relationship between fatigue and sleep has 
been reported in other studies [12, 32]. Fatigue was 
significantly correlated with subjective and objective 
measures of sleep in women with breast cancer [8]. 
Women with insomnia also reported significantly 
higher levels of depression, anxiety and fatigue [33].
Studies identify a significant relationship between 
sleep quality and mental health disorders including 
depression and anxiety [21, 22, 24-25, 34]. One 
group of researchers that investigated if breast 
cancer survivors (BCS) with insomnia can be grou-
ped according to their level of fatigue discovered 
significant differences in insomnia severity, anxiety, 
depression, and quality of life among the subgroups 
of exhausted, tired and restored [22].A study of 
prevalence, severity, and correlates of sleep-wake 
disturbances compares long-term breast cancer sur-
vivors (BCS) to age-matched women without breast 
cancer (WWC) and finds significant correlates of 
prevalence with poor sleep for BCS including hot 
flashes, poor physical functioning, depressive symp-
toms and distress [24]. 
The authors identify that comorbidity, evening 
fatigue, and depressive symptoms predicted base-
line levels of subjective sleep disturbance, and that 
depressive symptoms predicted the trajectory of 
subjective sleep disturbance [25]. Worse Physical 
Component scores were associated with reports of 
poor sleep and less recorded nap time, suggesting 
sleep plays an important role in cancer patients’ 
quality of life [8]. 
Discussion
Our review findings expose the overlooked disor-
ders of sleep in women with breast cancer and the 
associations with cancer-related fatigue (CRF), de-
pression and other important health issues. Further-
more, these 27 studies consistently document the 
high prevalence of poor sleep quality and decrease 
in quality-of-life. To begin to address this important 
patient care issue, we recommend use of tools like 
the PSQI, actigraphy and sleep diary for identifica-
tion and assessment of sleep quality in women with 
breast cancer. 
Comparisons between women with and without 
cancer revealed that breast cancer survivors had sig-
nificantly higher PSQI global scores, indicating poo-
rer sleep quality, as compared to women without 
breast cancer [24]. Another study comparing 30 fa-
tigued female breast cancer chemotherapy outpa-
tients and 32 non-cancer postmenopausal fatigued 
patients found a significantly longer sleep latency in 
the breast cancer group. Forty-seven percent of CRF 
patients expressed “severe difficulty” with sleep la-
tency, while 25% of postmenopausal women were 
in this category [16]. Additionally, women’s meno-
pausal status when starting chemotherapy was as-
sociated with differing patterns of sleep and hot 
flashes over time [4].
The grouping or “clustering” of cancer-related 
symptoms has been highlighted in recent reports 
as an important priority for nursing research. Grea-
ter knowledge is needed regarding the interaction 
of multiple symptoms and their potential impact on 
cancer patient outcomes if advances are to be rea-
lized in caring for persons diagnosed with cancer. 
The studies in this review inform health care pro-
fessionals to proactively assess for the continued 
presence of multiple symptoms once treatment has 
ended, with an understanding that a single, inten-
se symptom rarely occurs. Moreover, the focus of 
care should target the symptom interactions, and 
their association with quality of life. Those caring 
for cancer patients need to overcome the outdated 
practice of managing pain, fatigue, depression or 
poor sleep quality as isolated symptoms by concu-
rrently assessing and managing these related health 
problems [12, 22]. Tools such as PSQI, actigraphy 
and sleep diary can assist health professionals to 
assess the sleep quality of their female breast cancer 
patients. 
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The PSQI is a patient questionnaire designed 
to evaluate the subjective sleep quality and dis-
turbances that have been present during the past 
month. This questionnaire, which has been vali-
dated in several countries and languages, con-
tains 19 items that can be self-administered or 
employed in an interview, and 5 questions to be 
answered by roommates. The latter 5 questions 
are used only for information and are not scored. 
The 19 questions are grouped into seven sleep-
related components comprising quality, latency, 
duration, efficiency, disturbances, use of sleeping 
medication, and daytime sleepiness. The score 
of each component ranges from zero to three 
points. The overall score is obtained with the sum 
of components, ranging from zero to 21points. 
The higher the value obtained, the poorer sleep 
quality with the overall score of five points as 
the cut off for distinguishing between poor sleep 
quality (higher than five points) from good sleep 
quality (five points or less) [29]. 
Actigraphy is a technique for recording a persons’ 
sleep-wake pattern through recording of limb mo-
vements for a 24-hour cycle. This device is placed 
on the wrist of the non-dominant limb and detects 
motion, thus recording rest and activity. It provides 
data for interpretation in order to infer the presence 
of sleep or wakefulness. Frequent movements are 
interpreted as wakefulness, and low movements as 
sleep. It provides data on total sleep time, total time 
awake, number of awakenings, and sleep latency 
[35,36]. This objective measure records sleep and 
awake patterns. This tool is helpful to the health 
care professional as an adjunct to the PSQI and 
sleep diary; although, not commonly found in use 
outside of a sleep disorders center. 
Another means of assessing sleep patterns and 
sleep quality is a sleep diary, which is often used 
with actigraphy. This diary is usually completed for 
14 days by the patient to document sleep patterns, 
subjective sleep of quality and behaviors affecting 
sleep [8]. documented that this tool could be used 
to obtain reliable data about home sleep/wake 
patterns in women undergoing chemotherapy for 
breast cancer.
Studies in this review consistently found that 
poor sleep quality is experienced by female breast 
cancer patients. Nurses assess the responses that 
patients have to disease in order to select and im-
plement interventions to improve their quality of 
life. Because poor sleep quality is a frequent com-
plaint of women with breast cancer and decreases 
their quality of life, it is essential to routinely assess 
for sleep disruptions and intervene. The nurses’ 
evaluation of sleep quality should include the as-
sociated symptoms discovered in these studies that 
may be clustered with pain, fatigue, depression 
and others. And just one base population study 
was found on this study, it is necessary more future 
studies [37].
The sleep disturbances often become chronic 
and nurses need to make recommendations and 
to treat them because sleep disturbances are com-
mon among breast cancer survivors, even after 
completion of active cancer treatment, we need 
to be proactive to avoid the worst problems after 
treatment [10].
Interventions studies are very important and 
authors concluded MBSR may be an efficacious 
treatment to improve objective and subjective sleep 
parameters in breast câncer patients [17]. In another 
study, when compared with controls, the interven-
tion group demonstrated a significant increase in 
sleep duration with MBSR [18]. 
However, it is important to note that often the 
poor quality of sleep gets little attention from pa-
tients, who regard it as a “normal” consequence 
of the treatment. Despite the latest knowledge on 
this topic, many health care professionals do not 
identify and treat their patients’ sleep problems. If 
untreated, many sleep disorders can become chro-
nic health problems in patients with cancer, per-
sisting after treatment of the disease. Furthermo-
re, attention should be paid to the importance of 
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quality-of-life that has been frequently explored in 
the literature and encompasses sleep.
Limitations
There is a possibility that relevant articles were mis-
sed by this review. Future reviews are necessary 
to expand knowledge about the relationships bet-
ween sleep quality, fatigue, depression, and pain in 
women with breast cancer. 
Implications for Practice
An important aspect of nursing care for breast 
cancer patients is assessment for associated health 
problems, which includes sleep quality. We recom-
mend the use of validated screening tools such as 
the PSQI and sleep diary to assess for sleep distur-
bances. This assessment should be done at several 
key points in the cancer care process including the 
initial encounter prior to diagnosis, at diagnosis, 
during treatment, at the end of treatment, and at 
follow-up.
Furthermore, we recommend that nurses increa-
se their knowledge of normal and abnormal sleep 
to better assess for disorders, counsel their patients, 
and refer for further evaluation and management. 
Through regular assessment of sleep quality, nur-
ses can promote additional improvements in the 
quality-of-life for cancer patients. 
Conclusions
This review is relevant in view of the increased in-
cidence of breast cancer and the high prevalence 
of sleep disorders Assessing and identifying sleep 
problems in cancer patients should be a priority, as 
the disease is debilitating, and compromised sleep 
quality may further decrease functional ability. The 
negative effects of poor sleep quality can exacerba-
te other cancer-related symptoms and persist long 
after the end of treatment. We recommend that 
researchers focusing on breast cancer care should 
study the effectiveness of interventions that target 
the symptom cluster of poor sleep quality, pain, fa-
tigue, and depression to decrease the burden of this 
devastating disease. 
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